ribociclib
novartis
[' ribo', 'natalee']
the #oncoalerttoptweet day1 of #asco23 tweet by our oncoalert faculty natalee adjuvant ribo in early stage hr+ bc median f/u 34.0 months 57% at 2 ys, 20% at 3 yrs idfs: 90.4% vs 87.1% hr 0.748 p=0.0014 best 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨